Vein Clinic Growth Simulator

Interactive financial and operational modeling

Investor View
Patient Volume Source
Derived from market demand and clinic market share
15
patients/month

Select a preset location to auto-populate market assumptions, or choose Custom to set values manually.

Market Funnel Analysis

Market Funnel Flow

Population
500,000(100.0%)
Symptomatic Venous Disease (15%)
75,000(15.0%)
Intervention Candidates (40%)
30,000(6.0%)
Treatment Seekers - Annual (10%)
3,000(0.60%)
Monthly Treatment Demand
250(0.05%)
Clinic Capture (1.0%)
3(0.00%)
Serviceable Market
15(0.00%)
Serviceable Market (After Floor)
15.0
patients per month

⚠ Minimum floor applied: Population > 100,000 requires at least 15 patients/month

Funnel Parameters

500,000
15%
5%30%
40%
10%70%

Typical range: 30–50%. High-referral clinics: up to 60–70%.

10%
1%30%
1.0%
0.1%20.0%

Market Capture Analysis

Clinic Capture
3
patients/month
Untreated
247
patients/month
Conversion Rate
0.600%
Population → Annual Demand
Annual Opportunity
3,000
patients/year
Monthly Opportunity
250
patients/month
Market Headroom
247
uncaptured patients/month

Typical Treated Patients per Physician

New Braunfels:20–30 per month
Dallas / Forney:18–28 per month
Texas Average:20–30 per month

These are typical reference values for established practices. Actual patient volume depends on market demand, referral networks, and operational capacity.

Referral Benchmark

Projected patient volume based on referral network activity

Referring Physicians
10
Patients per Source
5
Conversion Rate
40%
Consults per Month
50
Projected Patients per Month
20

Volume Comparison

Market Demand Patients/Month
15
Referral Network Patients/Month
20

Benchmark Only

The referral calculation serves as a comparison benchmark. Patient volume is derived from market demand and clinic market share.

Calculation Method

Referring Physicians × Patients per Source10 × 5 = 50
Consults × Conversion Rate50 × 40% = 20

Annual Revenue

$1,687,170

First year projection

EBITDA Margin

48.9%

First year average

Break-even

Month 1

Time to profitability

Market Opportunity

$22,079,850

3,000 patients seeking treatment/year

Treatment Pipeline

Monthly procedure volumes based on new patient intake

New Patients per Month
15
Active Patients in Treatment
30
Ablations per Month
38
Varithena per Month
15
Sclerotherapy per Month
15
Total Procedures per Month
68

Pipeline Formulas:

  • • Active Patients = New Patients/Month × Treatment Duration
  • • Monthly Ablations = New Patients/Month × Ablations per Patient
  • • Monthly Varithena = New Patients/Month × Varithena per Patient
  • • Monthly Sclerotherapy = New Patients/Month × Sclerotherapy per Patient
  • • Total Procedures = Sum of all monthly procedures

Revenue Growth Projection

Month 1 Debug Values

Monthly Revenue
$110,399
Monthly Expenses
$66,675
Monthly EBITDA
$43,724
Verification: EBITDA = Revenue - Expenses → $43,724 = $110,399 - $66,675

Monthly Procedure Volume & Patient Pipeline

Avg Ablations/Month
48
Avg Varithena/Month
19
Avg Sclerotherapy/Month
19
Avg Active Patients
29

Active Patients = patients in treatment over the past treatment duration period. Procedures ramp up as the treatment pipeline fills.

EBITDA Margin Trend

Growth & Treatment

5.0%
0.0%20.0%

Treatment Pipeline

2 months
1 months6 months
2.5
0.05.0
1.0
0.05.0
1.0
0.06.0

Reimbursement

$2500
$1500$4000
$1800
$1000$3000
$400
$200$800

Procedure Supply Costs

$350
$100$800
$250
$100$500
$120
$50$300

Payer Mix

60%
0%100%
30%
0%100%
10%
0%100%
0%
0%100%
Total: 100%

Operating Expenses

$25000
$10000$60000
$8000
$3000$20000
$5000
$1000$15000
$10000
$2000$30000

Practice Scale

Model clinic expansion by adjusting staffing and equipment. Capacity scales proportionally with resources.

Number of physicians performing procedures

Number of equipped procedure rooms

Number of ultrasound machines available

Registered vascular technologists

Operational Capacity

Modeled clinic throughput assumptions — user-adjustable inputs, not market-derived values

Capacity Preset Scenarios

Current Capacity Analysis

Ultrasound Capacity

155

scans per month

Procedure Room Capacity(Bottleneck)

97

procedures per month

Physician Procedure Capacity

116

procedures per month

Effective Capacity

97

procedures per month

Note: These are modeled clinic throughput assumptions, not market statistics. Adjust to reflect actual staffing, room turnover, and scheduling. The effective capacity is limited by whichever resource becomes the bottleneck.

Expansion Impact

Capacity Constraint Detected

Your practice is operating at capacity. Expansion could significantly increase revenue.

Current Capacity

97

procedures/month

Projected Procedures

90

avg per month (Year 1)

Unused Demand

43

procedures not performed (Year 1)

Revenue at Current Scale

$1,687,170

Average capacity utilization: 88.9%

Revenue if Capacity Increased

$1,757,239

Additional revenue opportunity: $70,069

Expansion Recommendations

Revenue uplift: $70,069 (4.2% increase)

ROI timeframe: Consider staffing and equipment costs against the $5,839/month opportunity

Use the Practice Scale panel above to model different expansion scenarios and optimize capacity allocation.

Per Physician Economics

1 Physician

Metrics below show average performance per physician

Revenue per Physician

Below Target

$1,687,170

Benchmark: $2M-$3.5M annually

EBITDA per Physician

$825,771

Annual contribution to practice profitability

Procedures per Physician

On Target

1,032

Benchmark: 900-1,400 annually

Patients per Physician

Below Target

239

Benchmark: 240-480 annually (20-40/month)

Physician Utilization

Capacity Utilization74.0%

Optimal utilization: Physicians are operating at healthy capacity with room for growth.

Mature Practice Benchmarks

Revenue per physician:$2M-$3.5M annually
Procedures per physician:900-1,400 annually
New patients per physician:20-40 per month
Optimal capacity utilization:70-85%

Benchmarks based on typical mature vein practices. Early-stage practices may operate below these targets.

Treatment Timing

months

Time from initial consult to first procedure

months

Insurance pre-authorization processing time

months

Total time to complete all procedures per patient

Treatment Timeline Visualization

Month 0
Initial Consult

Patient evaluation and diagnosis

Months 0-1.5
Delay Period

Scheduling (1 mo) + Authorization (0.5 mo)

Month 1.5
Treatment Begins

First procedure performed, revenue starts

Months 1.5-3.5
Active Treatment Period

Multiple procedures distributed over 2 months

Month 3.5
Treatment Complete

Patient care concluded

Total Delay

1.5

months

Treatment Duration

2.0

months

Total Timeline

3.5

months

Impact on Financial Model:

  • • Revenue begins 1.5 months after patient consults
  • • First 2 months show low/zero revenue during ramp-up
  • • Procedures distributed evenly across treatment duration for realistic cash flow

Operational Capacity Reached

Your projected procedure volume exceeds current operational capacity. Revenue growth is being limited by available resources.

To continue growth, consider:

  • • Increasing clinic days per week
  • • Adding more procedure slots or rooms
  • • Hiring additional physicians or staff
  • • Extending operating hours

Capacity Inputs

User-adjustable operational assumptions — modify to reflect your clinic's staffing and scheduling

8
415
5
212
6
312
5
26
4.3
4.05.0

Market Structure

Payer Mix Distribution

Commercial60.0%
Medicare30.0%
Medicaid10.0%

Weighted Reimbursement Rates

Ablation:$2,178
Sclerotherapy:$348

Population Funnel

Symptomatic Venous Disease75,000

Population with symptomatic venous disease

Intervention Candidates30,000

Candidates requiring intervention

Annual Treatment Demand3,000

Patients seeking treatment per year

Monthly Treatment Demand250

Patients seeking treatment per month

Serviceable Market3

Patients capturable by clinic

Procedure Economics

Unit economics per procedure type

Ablation Procedures

Average Revenue per Ablation$2,178
Average Supply Cost per Ablation$350
Contribution Margin per Ablation$1,828
Margin Percentage83.9%

Varithena Procedures

Average Revenue per Varithena$1,568
Average Supply Cost per Varithena$250
Contribution Margin per Varithena$1,318
Margin Percentage84.1%

Sclerotherapy Procedures

Average Revenue per Sclerotherapy$348
Average Supply Cost per Sclerotherapy$120
Contribution Margin per Sclerotherapy$228
Margin Percentage65.6%

Contribution Margin

Contribution margin represents the revenue remaining after variable costs (supplies) to cover fixed expenses and generate profit. Higher margins indicate more profitable procedures.

Treatment Plan Economics

Combined economics per patient treatment course

Treatment Plan Composition
Ablations per Patient2.5
Varithena per Patient1.0
Sclerotherapy per Patient1.0
Revenue per Patient
$5,444 + $1,568 + $348
$7,360
Supply Cost per Patient
$875 + $250 + $120
$1,245
Contribution Margin per Patient$6,115
Margin Percentage83.1%

Per-Patient Treatment Economics

This shows the combined economics across all procedures delivered to a single patient throughout their complete treatment course. The contribution margin per patient represents the amount available to cover fixed costs and generate profit after variable supply costs.

Model Assumptions

Payer Reimbursement Multipliers

Each payer type reimburses at a different percentage of the base rate. These multipliers are applied to your base reimbursement rates to calculate weighted averages.

Commercial
100%
Medicare
72%
Medicaid
55%
Uninsured
15%

How Payer Mix Affects Revenue

Your effective reimbursement rate is calculated by multiplying each payer category's percentage by its multiplier:

Weighted Rate =
  (Base × Commercial% × 1.00) +
  (Base × Medicare% × 0.72) +
  (Base × Medicaid% × 0.55) +
  (Base × Uninsured% × 0.15)

A higher commercial payer mix increases revenue significantly, while a higher Medicaid or uninsured mix reduces it.

Population Coverage Model

Market opportunity is calculated from population demographics:

  • Venous Population: Total population × disease prevalence rate
  • Insured Population: Venous population × insured percentage
  • Serviceable Market: Insured population × clinic capture rate

The serviceable market represents your realistic addressable patient volume based on insurance coverage and competitive positioning.

Model Integrity

All charts, KPIs, and tables use the same calculation engine. The integrity badge at the top validates that all displayed values are derived from your inputs using consistent formulas. If any component displays hardcoded or stale data, the badge will alert you immediately.

Calculation Assumptions

Weighted Avg Ablation Reimbursement

$2,178

Weighted Avg Sclerotherapy Reimbursement

$348

Total Monthly Fixed Expenses

$48,000

Current Monthly EBITDA

$43,724